Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-07-23 Director's Dealing
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200723 - Transparantieverklaring persbericht FMR LLC .pdf
Director's Dealing Classification · 1% confidence The document is a formal notification ('Kennisgeving') issued by UCB NV regarding a change in significant shareholding by FMR LLC. It explicitly mentions crossing a threshold (3%) based on the law of May 2, 2007, concerning the disclosure of major shareholdings ('openbaarmaking van belangrijke deelnemingen'). This content directly corresponds to notifications about changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). The document details the exact number of shares and the resulting percentage held by the entity and its affiliates.
2020-07-23 Dutch
200717 - UCB Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details transactions where the company disposed of its own shares OTC following the exercise of stock options by personnel under various Long Term Incentive (LTI) Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). The specific filing category for this activity is 'Transaction in Own Shares' (POS). The document is a direct announcement of the transaction, not an announcement of a report, and its content is highly specific to share transactions.
2020-07-17 English
200717 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of options by employees as part of long-term variable remuneration. The table explicitly lists the date, quantity of UCB shares alienated, and the price. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the definition for Transaction in Own Shares (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a Director's Dealing (DIRS) as it relates to employee stock plans rather than director transactions specifically, although it is related to insider activity. The document is a direct report of the transaction, not an announcement of a report's publication.
2020-07-17 French
200717 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Vervreemding van eigen aandelen' (Disposal of own shares) and details transactions where UCB shares were delivered to employees as part of long-term incentive plans (stock options). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee share schemes. This aligns precisely with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance. The document is a formal announcement ('gereglementeerde informatie') detailing these transactions, not just an announcement that a report is available.
2020-07-17 Dutch
200710 - UCB Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Disposals of own shares" and details multiple transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various Long Term Incentive Plans. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. The appropriate code is POS (Transaction in Own Shares). The document is a formal announcement dated July 10, 2020, and is not merely announcing a separate report, thus RPA/RNS is less specific.
2020-07-10 English
200710 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of options by personnel, specifically mentioning the execution of Article 8:6 of the Royal Decree implementing the Companies and Associations Code. The core content is a detailed table listing the date, quantity of UCB shares alienated, and the price, which directly relates to the company buying back or selling its own shares (share repurchase/issuance). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a regulatory disclosure of these specific transactions, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2020-07-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.